ESR1 and cancer: Future studies using human NSCLC specimens are warranted to compare various factors, such as the amount, density, and type of tumor-infiltrating immune cells, clinical factors (including smoking history), genetic mutations of cancer cells, estrogen levels, and ER expression, to elucidate the influence of estrogen on tumor immunity in NSCLC.